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Abstract
Aims: The impact of the neonatal environment on the development of adult cardiovascular disease is poorly understood.
Systemic maternal inflammation is linked to growth retardation, preterm birth, and maturation deficits in the developing
fetus. Often preterm or small-for-gestational age infants require medical interventions such as oxygen therapy. The long-
term pathological consequences of medical interventions on an immature physiology remain unknown. In the present
study, we hypothesized that systemic maternal inflammation and neonatal hyperoxia exposure compromise cardiac
structure, resulting in LV dysfunction during adulthood.
Methods and Results: Pregnant C3H/HeN mice were injected on embryonic day 16 (E16) with LPS (80 mg/kg; i.p.) or saline.
Offspring were placed in room air (RA) or 85% O2 for 14 days and subsequently maintained in RA. Cardiac
echocardiography, cardiomyocyte contractility, and molecular analyses were performed. Echocardiography revealed
persistent lower left ventricular fractional shortening with greater left ventricular end systolic diameter at 8 weeks in LPS/O2
than in saline/RA mice. Isolated cardiomyocytes from LPS/O2 mice had slower rates of contraction and relaxation, and a
slower return to baseline length than cardiomyocytes isolated from saline/RA controls. a-/b-MHC ratio was increased and
Connexin-43 levels decreased in LPS/O2 mice at 8 weeks. Nox4 was reduced between day 3 and 14 and capillary density was
lower at 8 weeks of life in LPS/O2 mice.
Conclusion: These results demonstrate that systemic maternal inflammation combined with neonatal hyperoxia exposure
induces alterations in cardiac structure and function leading to cardiac failure in adulthood and supports the importance of
the intrauterine and neonatal milieu on adult health.
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Introduction
The impact of maternal health and the neonatal environment
on the development of adult cardiovascular disease has recently
been appreciated. Most notable are the investigations by Barker
and coworkers [1] correlating low birth weight and increased
cardiovascular mortality in adulthood. Since the first observations
by Barker [2], several studies have expanded this association with
low birth weight to include the development of hypertension,
insulin resistance, and coronary artery disease. Furthermore, epi-
demiological studies suggest that factors leading to adult cardio-
vascular diseases are already present during childhood.[3,4]
A substantial portion of cardiovascular disease cannot be
directly correlated with common risk factors or preexisting
diseases, implicating a more subtle origin as the pathologic source.
Studies focusing strictly on low birth weight have not revealed
precise risk factors in humans. Furthermore, animal models have
not identified specific mechanisms for the influences of birth
weight on adult health.[5,6,7] Consequently, the impact of
intrauterine and early neonatal influences on developmental
programming due to low birth weight or early gestational age
and cardiovascular health warrants further investigations.[7]
Preterm birth and thus low birth weight occurs in approximately
12% of the population and results from a broad range of diverse
conditions often brought on by poor maternal health or inflam-
mation.[8] Systemic maternal infections or sources of inflammation
such as periodontal [9], urinary tract [10], or respiratory infections
[11] areoftenignoredinthe contextoffetaldevelopment.However,
the fetus is exposed to increased expression of cytokines,
chemokines, and/or lipid mediators through the circulation as a
result of maternal inflammation.[12,13]
In utero exposure to maternal inflammatory mediators is likely to
impact the fetus and can result in fetal programming, either
physiologically or epigenetically. In addition, chronic inflammatory
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neonatal outcomes, specifically increasing the incidence of preterm
birth.[8,14,15] Recently, animal models have demonstrated that
maternal hypercholesterolemia can alter arterial gene expression,
vascular reactivity, and cause endothelial dysfunction, accelerating
atherosclerosis in the offspring.[6,16] Other animal models have
demonstrated an association between maternal undernutrition,
hypoxia exposure, and the development of hypertension.[14,17,18]
The intrauterine effects are often compounded by the events
associated with birth and the implementation of life sustaining
medical interventions such as oxygen administration during the
perinatal period. Animal studies have demonstrated effects of
maternal hypoxia on cardiovascular development in the offspring.
Specifically relevant are the findings that hypoxia interferes with
inotropic stimulation and changes the sensitivity of adrenergic
receptors resulting in permanently altered responses [19,20,21,22].
Conversely, hyperoxia exposure also poses a threat to the developing
cardiovascular system and negatively impacts the neonate. Yzydorc-
zyk et al. have identified changes in systolic and diastolic blood
pressure and increased resting heart rates in adult rats following
neonatal exposure to hyperoxia.[23] Most recently, Seehase et al.
reported that antenatal exposure of fetal sheep to endotoxinaemia
resulted in cardiac inflammation and dysfunction within 3 days.[24]
However, the consequences of neonatal hyperoxia exposure on
developing organ systems other than the lung have not been
extensively investigated. The combined effects of maternal inflam-
mation, preterm or small infants, and postnatal interventions such
as hyperoxia are likelyto have profound effects on offspring, making
them vulnerable to the development of adult diseases.
In the present study, we hypothesized that the combination of
systemic maternal LPS administration and medical interventions
such as neonatal hyperoxia exposure would alter cardiac develop-
ment, impairing function later in life. Our model of systemic
maternal inflammation and neonatal hyperoxia exposure offers a
novel approach to investigate the influence of the neonatal
environment on the developing cardiovascular system and may
provide new insights into the etiology of adult heart failure.
Results
Body weights and LV weights at 8 weeks of age
Maternal inflammatory response to LPS was assessed in lung
tissue from pregnant dams 4 h after i.p. LPS or saline injection on
embryonic day 16 (E16). LPS injection induced a robust TNFa
(saline 1.1060.31 vs. LPS 6.5760.68) and IL1-b (saline 1.266
0.61 vs. LPS 6.9061.47) mRNA increase in the lungs of pregnant
dams. To investigate in the duration of the maternal inflammatory
response to a single LPS injection we assessed KC protein levels
in maternal serum on E17 and E19. LPS injection significantly
increased KC levels in maternal serum on E17 (saline 0.396
0.15 ng/ml vs. LPS 1.5160.28 ng/ml) and E19 (saline 0.386
0.23 ng/ml vs. LPS 0.8960.22 ng/ml). All saline injected and
80% of the LPS injected dams gave birth at term. No differences
were observed in litter sizes (saline 6.760.2 vs. LPS 6.360.4 pups)
or gender distribution between saline or LPS injected dams that
gave birth.
Body weights were not different through the first 2 weeks of life
(data not shown). However, at 8 weeks of age, body weights were
significantly lower in LPS/O2 compared to saline/RA exposed
mice, while each single exposure (saline/O2 or LPS/RA) had no
effect (Table 1). Histologically there were no gross differences in
heart structure or size of the LV or RV. LV wet weights were
lower at 8 weeks of age, in LPS/O2 than in saline/RA mice, while
single exposures had no effect (Table 1). After normalizing LV wet
weight to body weight, LPS/O2 mice still exhibited a lower LV to
body weight ratio compared to the saline/RA mice. However,
absolute liver weights or liver weights normalized to body weights
were not different between groups (Table 1).
Echocardiography
Echocardiographic parameters of LV structure and function were
assessed at2 and 8 weeks of age (Figure1 andTable2). At2 weeksof
age, fractional shortening (FS) was modestly lower in the saline/O2
and LPS/RA than in the saline/RA exposed mice but severely
decreased in LPS/O2 exposed animals(Figure 1A). Furthermore, FS
remained lower in LPS/O2 exposed mice at 8 weeks of age, while
LV systolic function was not different in saline/O2 and LPS/RA
exposed mice compared to saline/RA controls (Figure 1A). No
differencewas found inLV end diastolic diameter(LVEDd)i na n yo f
the groups (Table 2). However LV end systolic diameter (LVESd)
tended to be greater at 2 weeks and was increased significantly at 8
weeks of age in LPS/O2 expose mice compared to all other groups
(Figure 1B). Cardiac output (CO) was slightly but not significantly
lower at 2 weeks but was significantly decreased at 8 weeks of age in
LPS/O2 compared to single treated or saline/RA exposed mice
(Figure 1C). All treatments significantly decreased posterior wall
thickness (PWT) at both time points, although PWT was even lower
in LPS/O2 compared to saline/O2 and LPS/RA exposed mice at 8
weeks of age (Figure 1D). Ejection fraction (EF) was lower in LPS/
O2 exposed mice at 2 and 8 weeks of age compared to all other
groups. At 2 weeks of age LV end systolic volume (LVESV) was
greater in LPS/O2 e x p o s e dm i c ec o m p a r e dt ob o t hs a l i n et r e a t e d
groups and at 8 weeks of age greater than all groups. Stroke volume
(SV) waslowerat 8 weeksofage inLPS/O2 exposed micecompared
to controls. No differences were observed in heart rate (HR) or LV
end diastolic volume (LVEDV) at any time point (Table 2).
Cardiomyocyte function
Assessment of cardiomyocyte function was performed on
isolated cells obtained from mice at 8 weeks of age. Cell shortening
(%PS) at 1 Hz was increased ,40% in cardiomyocytes isolated
from the LPS/RA compared to all other groups (Figure 2A) and
was associated with increased maximal shortening and relengthen-
ing velocities (6dL/dt)(Figure 2B). Interestingly, %PS and
velocities (6dL/dt) were not different between the saline/O2
and the saline/RA controls, however both the time to 90%
contraction and relengthening were longer. In contrast, contrac-
tility was decreased by ,20% in the LPS/O2 group and was
associated with an increase in time to 90% contraction (TPS 90;
Table 1. Body, left ventricle, and liver weights from 8 week
old mice after prenatal saline or LPS and neonatal RA or
hyperoxia exposure.
Saline RA Saline/O2 LPS/RA LPS/O2
body weight
(BW) [g]
24.2960.50 22.4860.55 23.0460.50 20.7660.49 *
left ventricle
(LV) [mg]
75.5961.60 69.8962.76 74.6762.07 63.8961.65 *
LV/BW 3.1460.08 2.9960.09 3.1060.06 2.8660.08 *
liver weight [g] 1.41360.05 1.31960.05 1.30460.04 1.26060.04
liver/BW 60.0262.47 60.9762.37 58.0661.28 60.9861.53
Data were analyzed by one-way ANOVA followed by Bonferroni post hoc.
n=21–24 mice per group p,0.05 compared to saline/RA exposed mice.
doi:10.1371/journal.pone.0024544.t001
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Furthermore, increased time to 90% relengthening (TR 90;
Figure 2D) and decreased maximal relengthening velocity
(Figure 2B) were also observed.
a-Myosin Heavy Chain (a-MHC) and b Myosin Heavy
Chain (b-MHC) protein measurements
LV a-MHC protein content was significant increased in all
treatmentgroupscomparedtosaline/RA exposedmice (Figure3A).
Conversely, b-MHC protein contents were not affected in saline/
O2 but significantly reduced in LPS/RA and LPS/O2, exposed
mice (Figure 3B). The ratio of a-t ob-MHC indicates a pronounced
shift toward the more energy consuming a-MHC in the LPS/O2
exposed mice (Figure 3C).
Connexin-43 immunohistochemistry and protein
Histological assessments revealed fewer connexin-43 positive
gap junctions,with positive staining more lateralized inalltreatment
Figure 1. Functional and morphological parameters achieved by M-mode echocardiography of mice exposed to maternal saline or
LPS on E16 and 14 days of neonatal RA or O2 at 2 and 8 weeks of age. Data were analyzed using two-way ANOVA and Bonferroni post hoc,
n=8–9 mice per group, p,0.05 compared to saline/RA (*), saline/O2 ({), or LPS/RA ({) exposed mice.
doi:10.1371/journal.pone.0024544.g001
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connexin-43 protein content was reduced in all treatments
compared to saline/RA exposed mice (Figure 4B).
Nox4 and VEGFA protein expression
Nox4 protein levels were dramatically decreased in both LPS/
RA and LPS/O2 exposed mice compared to the saline groups at
days 3 and 7 (Figure 5A). At day 14, the LPS/RA mice had
compensated and NOX 4 levels were no longer different than the
saline groups but different than LPS/O2 (Figure 5A), while Nox4
expression in the LPS/O2 groups was persistently decreased.
Decreases in Nox4 protein levels in the LPS-treated mice
coincided with decreases in VEGFA expression at day 3 however,
at days 7 and 14, there was no significant difference in VEGFA
among the groups (Figure 5B).
Capillary Density in the LV myocardium
Capillary density was assessed in LV tissue sections by
immunostaining with CD31 (brown staining indicates vessels
,50 microns in diameter, Figure 6A). No apparent abnormalities
in endothelial structure within the vessels were observed in
histological analyses. Capillary counts revealed fewer capillaries in
the LPS/O2 exposed mice than in all other exposure groups
(Figure 6B).
Discussion
This study provides the first evidence that the combination of
systemic maternal inflammation and neonatal hyperoxia exposure
creates synergistic responses in the developing rodent, resulting in
prolonged, adverse LV structural and functional changes.
Furthermore, these adverse changes are manifested as persistent
LV systolic dysfunction in vivo and both systolic and diastolic
dysfunction in vitro.
Maternal inflammation was documented by measurement of
TNFa, IL-1b in maternal lung tissues and KC in the plasma of the
dam through the remainder of gestation. In the present study, all
dams that gave birth had similar litter sizes and pup weights.
However, at 8 weeks of age, the LPS/O2 exposed mice weighed
less than all other groups (Table 1), indicating a developmental
impact of early exposures that was not manifested until adulthood.
Others have described cardiac dysfunction in response to multiple
maternal insults during fetal development with and without a
reduction in birth weight.[25,26] However, our findings are
consistent with studies by Rueda-Clausen et al. [18] which
observed lower body weights at 12 months of age in rats born to
hypoxia exposed dams.
Adverse maternal environments can induce LV remodeling
leading to cardiac dysfunction.[27,28,29,30,31,32] Studies by Bal
et al. have observed decreased LV weight in response to neonatal
dexamethasone treatment which resulted from inhibition of
mitosis and a reduced number of cardiomyocytes at adult-
hood.[33] In the LPS/O2 exposed mouse pups, lower LV weights
were observed at 8 weeks, with this difference remaining even after
correcting for body weight (Table 1). Neither total liver weight nor
liver weight normalized to body weight was different in any group
indicative of no overall alterations in body weight (Table 1). The
decreased LV weight was consistent with a decrease in LV
posterior wall thickness indicating lower muscle mass and was
most pronounced in the combined treatment group suggesting
synergism between the maternal LPS and neonatal hyperoxia
exposure.
Lower LV weights correlated with increased LV end systolic
diameter and decreased FS in LPS/O2 exposed mice (Figure 1)
and indicate a systolic dysfunction that is distinct from diastolic
dysfunction previously reported.[18,34,35] Systolic dysfunction is
indicative of more severe cardiac dysfunction, and has not been
previously described in animal models of maternal/neonatal
exposure. Interestingly, these data are consistent with cardiac
dysfunction observed at 5 years of age in humans that were born
small for gestational age.[36]
The systolic dysfunction observed was further investigated at the
cellular level in isolated cardiac myocytes. Interestingly, LPS alone
actually increased cardiac myocyte contractility in response to
electrical pacing at 1 Hz (Figure 2) and increased the kinetics of
both shortening and relaxation. In adult rodents, the myocardial
consequences of LPS-induced sepsis are hypotension and cardiac
hypocontractility.[37,38] However, the fetus is able to respond
Table 2. LV end diastolic diameter (LVEDd), Ejection Fraction (EF), LV end systolic volume (LVESV), LV end diastolic volume
(LVEDV), stroke volume (SV), and heart rate (HR) at 2 and 8 weeks of age.
2 weeks saline/RA Saline/O2 LPS/RA LPS/O2
LVEDd [mm] 3.0660.06 2.8960.05 3.0860.06 2.9360.04
EF [%] 66.7661.11 61.3661.23 61.2662.59 50.3661.21 *{{
LVESV [ml] 12.3260.67 12.4460.62 14.2061.40 16.4560.61 *{
LVEDV [ml] 37.0561.81 32.1461.14 * 36.0260.63 33.0961.00
SV [ml] 27.1861.45 26.4062.16 27.1761.49 22.3861.53
HR [bpm] 471.365.72 487.568.17 465.065.65 494.068.00
8 weeks saline/RA Saline/O2 LPS/RA LPS/O2
LVEDd [mm] 3.9060.08 3.7760.07 3.9160.20 3.960.2
EF [%] 63.0760.73 61.2061.38 62.4261.65 44.5461.61 *{{
LVESV [ml] 24.8661.46 23.8061.70 23.1161.37 36.2364.75 *{{
LVEDV [ml] 66.4663.07 61.2962.95 62.1963.71 67.0667.01
SV [ml] 43.1060.82 40.1162.36 41.5363.71 31.5862.71 *
HR [bpm] 468.2614.9 448.0610.3 450.066.6 439.568.3
n=8 (4 males, 4 females), p,0.05 compared to saline/RA (*), saline/O2 ({), and LPS/RA ({).
doi:10.1371/journal.pone.0024544.t002
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maternal sepsis, for self-preservation.[39] In the present study, this
adaptation persists through adulthood, so called predictive
adaptation. Conversely, the LPS/O2 myocytes exhibited impaired
contractile performance as evidenced by the kinetics of shortening
and relaxation (Figures 2C, 2D), which indicates that the fetal
adaption was not sufficient to sustain contractility if mice were
subsequently exposed to oxygen. Collectively, these data indicate
that the combination of LPS and O2 exposure causes a unique
phenotype which may account for the contractile defects observe
in vivo. Often the results obtained in cardiomyocyte function are
different than what is observed in vivo. This was the case in our
study and is potentially due to alterations in the functional
architecture of the heart. Interestingly, it is apparent that the
cardiomyocyte is specifically targeted by LPS treatment as
evidenced by the times required for 90% contraction or relaxation
which is indicative of diastolic dysfunction. The slower rates of
myocyte relaxation in vitro were not yet manifested as diastolic
dysfunction in vivo. This may be attributed to several factors,
including the presence of neurohormonal influences in vivo that
were not present in the isolated cell culture, alteration in
intercellular electrical mechanical coupling, and or changes in
Figure 2. In vitro cardiomyocyte function in saline/RA and LPS/O2 exposed mice at 8 weeks of age. (A) % Peak shortening (% PS) was
increased in the LPS/RA exposed mice. (B) Shortening velocity (Dep) and relengthening velocity (Rel) was significantly increased in cardiomyocytes
isolated from LPS/RA exposed mice and decreased in LPS/O2-exposed mice compared to saline/RA controls. (C) Time-to-90% shortening (TPS 90) was
significantly increased in cardiomyocytes isolated from saline/O2 and LPS/O2-exposed mice, indicating systolic dysfunction at the cellular level. (D)
Time-to-90% relengthening (TR 90) was significantly increased in myocytes from saline/O2 and LPS/O2-exposed mice, indicating significant diastolic
dysfunction at the cellular level. Data were analyzed using one-way ANOVA and Bonferroni post hoc, *p,0.05, n=20 cells per mouse and three to
five mice per group. p,0.05 compared to saline/RA (*), saline/O2 ({), or LPS/RA ({) exposed mice.
doi:10.1371/journal.pone.0024544.g002
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studies indicated no evidence of fibrosis or changes in matrix
composition.
One mechanism that may underlie the decreased contractile
kinetics in LPS/O2 cardiomyocytes is the myosin heavy chain
isoform switching. In the rodent heart, the a-MHC isoform
expression predominates in healthy cardiac tissue, and a transition
to greater b-MHC levels occurs during pathological LV
remodeling and experimental heart failure in a variety of adult
animal models.[40] Specific nutritional deprivations have also
been shown to cause alterations in cardiac structural proteins and
result in ventricular dysfunction.[41] However, at 8 weeks of age,
significant increases in a-MHC, which exhibit a higher ATPase
activity and sliding velocity than the b-MHC isoform [42], were
evident in either single LPS or O2 treatments or in the combined
treatment group (Figure 3). Surprisingly, b-MHC was decreased
by LPS in LV tissues and unchanged in the other group (Figure 3B)
which was contrary to other animal models of cardiac diseases.
Furthermore, a shift toward a-MHC in the LPS/O2 exposed mice
was further evident when relative ratios of a-t ob-MHC were
analyzed (Figure 3C). Taken together, these alterations in a-
MHC/b-MHC levels in our model identify a unique alteration in
MHC isoform expression and may partially explain the reduced
contractile kinetics in the LPS/O2 isolated cardiac myocytes.
However the shift toward increased a-MHC, a more energy
demanding and greater force generating isoform, is likely a
compensatory mechanism by which the mice are able to maintain
homeostasis is the face of contractile deficiency. [43,44]
Decreased levels and/or dislocation of connexin-43 positive gap
junctions are strongly correlated with heart failure.[45,46] We
observe a translocation and lateralization of connexin-43 gap
junctions in all treatment groups that was most pronounced in
LPS/O2 compared to the saline/RA exposed mice (Figure 4). The
change in localization corresponds to lower overall connexin-43
protein levels in the LPS/O2 exposed mice and is likely
contributing to the contractile deficits we observe. Lateralization
is thought to occur when connexin-43 is hyperphosphorylated and
just prior to degradation. This change in location and phosphor-
ylation state prevents connexin-43 proteins from integrating into
the gap junction structure and contributes to the slowing of
longitudinal conduction velocity.[47]
Histological examination of whole heard sections revealed no
difference in the size and shape of the heart but a decreased
number of capillaries was noted. Capillary formation in the
myocardium is driven largely by the paracrine expression of
vascular endothelial growth factor (VEGF). VEGF expression and
activity is regulated by changes in oxygen tension and the
formation of reactive oxygen species (ROS) which are produced in
Figure 3. MHC protein contents in LV tissues at 8 weeks of age. Representative Western blots and quantified data indicating changes in a-
MHC and b-MHC protein contents due to LPS, O2 or combined treatments. Data were analyzed using one-way ANOVA and Bonferroni post hoc, n=5
mice per group, p,0.05 compared to saline/RA (*) exposed mice.
doi:10.1371/journal.pone.0024544.g003
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heart, ROS are readily produced in part by the activity of
NADPH oxidases (NOX). In particular, Nox4 facilitates capillary
formation by stabilizing hypoxia inducible factor 1 and increasing
the expression of VEGF, resulting in angiogenic activity.[48] In
the present study, Nox4 expression was severely depressed in the
heart of mice exposed to LPS at days 3 and 7 and remained
depressed in the LPS/O2 exposed mice even at 14 days (Figure 5A).
The decreases in Nox4 expression in the LPS/O2 exposed mice
wereaccompanied by the early deficits inVEGF expression at day3
(Figure 5B). Although VEGF expression returns to control levels by
day 7, the early developmental deficiency in VEGF expression at a
potentially critical time point could permanently effect capillary
formation leading to reduced density as evident at 8 weeks of age
(Figure 6). Although our findings indicate an acute and temporally
defined VEGF deficit, the phenotype observed in LPS/O2 exposed
mice is remarkably similar to that reported by Giordano et al. [49]
in a cardiomyocyte-specific VEGFA knockout. They reported
contractile dysfunction, ventricular wall thinning and decreased
capillary density without changes in the major vessels.
The phenotype of the LPS/O2 exposed mice is complex. Our
data indicate that these mice exhibit ventricular wall thinning,
decreased cardiac contractility, and impaired myocardial capillary
formation. The collective pathologies could result from a single
defect early in development, however this is unlikely given that the
maternal inflammation is induced at E16, well into the third
trimester of development after most of the key events in heart
formation, and the hyperoxia exposure occurs after birth. It is
interesting, however, that the VEGFA knockout mice reported by
Giordano [49] have similar phenotypes resulting from ablation of
a single gene. Obviously, expression and regulation of VEGFA in
our models warrants further investigations.
In conclusion, the present study highlights the impact of the
perinatal environment on cardiac development and its effects on
structural and functional changes in the adult heart. The extremely
preterm infants born to mothers with systemic inflammation and
Figure 4. Connexin-43 proteins in LV tissues at 8 weeks of age. Representative confocal images showing reduced numbers of connexin-43
positive gap junctions and CX-43 lateralization in saline/O2, LPS/RA, and LPS/O2 compared to saline/RA-exposed mice (Figure 6A). Representative
Western blots and quantified data indicating significantly reduced connexin-43 content in LPS/O2 compared to saline/RA exposed mice (Figure 6B).
Data were analyzed using one-way ANOVA and Bonferroni post hoc, n=5 mice per group, p,0.05 compared to saline/RA (*) exposed mice.
doi:10.1371/journal.pone.0024544.g004
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only in the last ,20 years. The phenotype observed in our model is
severe and may exaggerate the disease propensity in human infants
however, Bassero et al. have observed long QT intervals in ex-
extremely preterm infants as early as 20–21 years of age.[50] Our
model offers a basis to begin to understand the mechanisms behind
the pathologies that this unique population is likely to face. The
impact of an adverse perinatal environment on cardiovascular
health may be not be evident until additional risk factors are
introduced in adulthood and could be the underlying source of
idiopathic cardiac events, specifically in this population. The need
forbetterunderstandingthelong-termconsequencesofthefetaland
neonatal environment is obvious and could provide alternative
approaches to the development of interventional strategies.
Methods
Animal Model
All animals were handled in accordance with NIH guidelines
and protocols were approved by the Institutional Animal Care and
Use Committee at the Research Institute at Nationwide Children’s
Hospital. Male and female C3H/HeN mice were paired and the
presence of a vaginal plug was designated as embryonic day one
(E1). In preliminary studies, we investigated in the highest LPS
dose that if injected to pregnant dams on E16 resulted viable litter
without differences in size or life born pups. On E16, pregnant
dams were injected with LPS (80 mg/kg i.p., serotype 0111:B4
Calbiochem, #437627), or an equal volume of saline. After birth
2 liters of newborn mice born to saline or LPS injected dams were
Figure 5. Western blot assessments of Nox4 and VEGFA protein levels. Representative Western blots and quantified data indicating
changes in Nox4 and VEGFA protein contents due to LPS treatment. Data were analyzed using one-way ANOVA and Bonferroni post hoc, n=5 mice
per group, p,0.05 compared to saline/RA (*), saline/O2 ({), or LPS/RA ({) exposed mice.
doi:10.1371/journal.pone.0024544.g005
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treatments) and placed in separate cages. One dam and litter was
placed in a plexiglass chamber containing a 10 L/min flow of 85%
O2 while the corresponding dam and litter were placed in room
air (RA). One litter of pups was exposed to 85% O2 for 2 weeks
(saline/O2, LPS/O2) and then returned to room air (RA) while the
other litter of pups was maintained in RA (saline/RA, LPS/RA).
The dams were switched every 24 h to prevent oxygen toxicity.
Twenty-four hours of hyperoxia exposure was designated as day 1.
Echocardiography studies
At 2 and 8 weeks of age, mice were anesthetized with isoflurane
and placed in a supine position on a physiological warming pad.
Echocardiographic evaluations were performed using a VisualSo-
nics Vevo 2100 Ultra High Resolution In Vivo Imaging System
(VisualSonics, Toronto, ON, Canada). Scanning was performed at
a frequency of 20MHz and three measures at different cardiac
cycles were assessed and used for analysis. M-mode images were
obtained in the parasternal short axis view at the level of the
papillary muscles to assess left ventricular (LV) end systolic
diameter (LVESd) and LV end diastolic diameter (LVEDd). Stroke
volume (SV) was determined using Doppler flow Velocity-Time
Integral (VTI) at the LV outflow tract (LVOT) and the aortic
diameter (Ao), (LVOT
2 * 0.785 * Ao VTI). Cardiac output was
calculated from stroke volume multiplied by heart rate (SV*HR).
Systolic function was assessed using M-mode calculations of
fractional shortening (FS=LVEDd-LVESd/LVEDd) LV end
diastolic volume (LVEDV) was calculated from LVEDd (7/
(2.4+LVEDd)*LVEDd
3). LV end systolic volume (LVESV) was
calculated from LVESd (7/(2.4+LVESd)*LVESd
3) and ejection
fraction (EF=(LVEDV-LVESV)/LVEDV*100).
Isolation and functional assessments of LV
cardiomyocytes
At 8 weeks of age, left ventricular cardiomyocytes were isolated
by retrograde aortic perfusion with liberase and cultured until the
Figure 6. Capillary density was assessed in LV tissues by immunohistochemistry. Images of tissue sections were immuno-stained for CD31
(Figure 6A). Capillary numbers were counted in 5 high power fields (HPF) per slide and n=3 mice per group (HPF=22,000 mm
2). Data were analyzed
using one-way ANOVA and Bonferroni post hoc, p,0.05 compared to saline/RA (*), saline/O2 ({), or LPS/RA ({) exposed mice.
doi:10.1371/journal.pone.0024544.g006
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adherent to laminin coated imaging chambers were loaded onto
the stage of an inverted microscope (Olympus IX-70, Olympus
Corporation, Tokyo, Japan). Cells were perfused with heated
contractile buffer (131 mM NaCl, 4 mM KCl, 10 mM HEPES,
1 mM CaCl2, 1 mM MgCl2, and 10 mM Glucose) at 37uC, and
stimulated with a suprathreshold voltage using two platinum wires
at a frequency of 1.0 Hz. Myocyte mechanics (twitches) were
assessed using a Myocyte Calcium Imaging/Cell Length System
(Ionoptix, Milton, MA). Data were acquired with a Soft Edge
MyoCamH system (IonOptix Corporation, Milton, MA, USA).
Cell shortening (a measure of cellular systolic function) and re-
lengthening (a measure of cellular diastolic function) as well as time
for each were measured on individual cells using video recorded
images. These data are reported as peak shortening normalized to
baseline sarcomere length (%PS), time-to-90% shortening (TPS
90), time-to-90% relengthening (TR 90), and the maximal
velocities of sarcomeric shortening and relengthening (6dL/dt).
Immunoblot analyses of LV tissue
LV protein lysates were separated by SDS-PAGE and
transferred to PVDF membranes. Membranes were probed with
antibodies to a-MHC (1:1000, Genway, 20-272-191956, San
Diego, CA), b-MHC (1:500, Santa Cruz, sc71575, Santa Cruz,
CA), Nox4 (1:5000, a generous gift from Dr. Reto Asmis), VEGFA
(1:500, Santa Cruz, sc-152, Santa Cruz, CA), connexin-43
(1:5000, Santa Cruz, sc-9059, Santa Cruz, CA), followed by their
corresponding secondary antibodies. Bands were visualized using
ECL detection and quantified with densitometry using Image-
Quant software, v5.0 (Molecular Dynamics). Band densities were
normalized to b-actin (1:10000, Abcam, ab6276, Cambridge, MA)
or total ERK protein (1:10000, Abcam, ab16869, Cambridge,
MA).
Immunohistochemistry
Heart sections (5 mm) were deparaffanized, blocked, and treated
with CD31 antibody (1:100, Santa Cruz, sc-1506, Santa Cruz,
CA) or connexin-43 (1:100, Santa Cruz, sc-9059, Santa Cruz,
CA). Secondary antibody and ABC reagents including 3,39-
Diaminobenzidine (DAB) were used as the peroxidase substrate for
CD31 and hematoxylin was used to counterstain. For connexion-
43 staining, Alexa Fluor 488 (Invitrogen, Carlsbad, CA) was used
as the secondary antibody and viewed with fluorescent microsco-
py. Unique photomicrographs from each treatment were recorded
at (1006) and capillaries counted by an investigator blinded to
group assignment.
Statistical analyses
Data are presented as mean 6 SEM. Statistical analyses were
performed using two-way ANOVA followed by Bonferroni post-
hoc analyses. P,0.05 was considered statistically significant.
Analyses were performed using GraphPad PRISM 5 (La Jolla,
CA).
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